Searched for
ROBERT J COURY
Biocon Biologics acquires Viatris' biosimilar business for $3.34 billionBBL said the cash payment of $2 billion to be funded by $800 million raised through equity infusion in BBL and the remainder to be funded b...
28 Feb, 2022, 07.50 AM IST
Mylan rejects Teva's $40 billion merger offer as undervaluedDrug major Mylan has rejected a $40 billion unsolicited merger offer from Israel's Teva Pharmaceutical Industries calling the bid undervalu...
28 Apr, 2015, 03.25 PM IST
- Matrix weighs Docpharma sale
Hyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.
29 Feb, 2008, 12.04 AM IST
- US pharma major Mylan buys Matrix Labs
The generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.
29 Aug, 2006, 01.58 AM IST